InDevR
Business Services · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6035 Longbow Dr Ste 102, Boulder, Colora...Phone Number
(303) 402-9100Website
www.indevr.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About InDevR
About InDevR-Based in Boulder, CO, InDevR is a biotechnology company poised to significantly impact vaccine process optimization and manufacturing with powerful new protein characterization tools. Venture-backed by Adjuvant Capital and funded by the Bill & Melinda Gates Foundation, InDevR has launched several successful life science tool product lines to enable vaccine development and serological research. InDevR also provides testing and custom services for biotherapeutic companies.Explore more
InDevR Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InDevR your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if InDevR had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at InDevR
Earning: See what the market has to say on InDevR recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if InDevR is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when InDevR launches new products
Check if InDevR has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once InDevR has new funding data
InDevR, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined InDevR as Masked Content
Find 3 more new buyers
Compare Similar Companies to InDevR
Compare insights from companies similar to InDevR, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InDevR is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InDevR is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InDevR.
InDevR financials insights
Gather financial insights about InDevR, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Grant
$2.9M
2019
Series A
$7M
2020
Debt
$350K
2023
Series B
$9M
InDevR Tech Stack
A closer look at the technologies used by InDevR
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Product Launch
Product Launch
Facilities Relocation / Expansion
InDevR is planning to move offices in September 2024. The move will impact employees at the existing office located at 6035 Longbow Dr Suite 102, Boulder, CO.
Facilities Relocation/Expansion
Open Position
Open Position
InDevR News & Media
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
New partnerships will drive the commercial expansion of InDevR’s game-changing solutions for vaccines and biotherapeuticsGlobal Cell Counting Market Report 2022: Growing Prevalence of Cancers to Drive Future Growth - Forecasts to 2026 & 2031
DUBLIN, Sept. 8, 2022 /PRNewswire/ -- The "Cell Counting Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global cell counting market is expected to grow from $8.44 billion in 2021 to $9.02 billion in 2022 at a compound annual growth rate (CAGR)...Cell Counting Global Market Research Report 2022 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Cell Counting Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global cell counting market is expected to grow from $8.44 billion in 2021 to $9.02 billion in 2022 at a compound annual growth rate (CAGR) of 6.87%. The cell counting market is expected to grow to $11.83 billion in 2026 at a compound annual growth rate (CAGR) of 7.01%. The cell counting market consists of sales of cell countingGlobal $9 Bn Cell Counting Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Cell Counting Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global cell counting market is expected to grow from $8.44 billion in 2021 to $9.02 billion in 2022 at a compound annual growth rate (CAGR) of 6.87%. The cell counting market is expected to grow to $11.83 billion in 2026 at a compound annual growth rate (CAGR) of 7.01%. The cell counting market
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InDevR
Sign Up For FreeTo access detailed company insights
About InDevR-Based in Boulder, CO, InDevR is a biotechnology company poised to significantly impact vaccine process optimization and manufacturing with powerful new protein characterization tools. Venture-backed by Adjuvant Capital and funded by the Bill & Melinda Gates Foundation, InDevR has launched several successful life science tool product li... Read More
